GlassScriptPhysician profile
Walter Rayford
NPI 1821103151
$26,028.27
in general payments reported to CMS, 2019-2025
68 companies · $4,863 in 2025
The $4,863 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,342 · 2020: $3,077 · 2021: $3,853 · 2022: $4,099 · 2023: $5,425 · 2024: $3,369 · 2025: $4,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $3,439 · Education: $39.99 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,154.52 |
| Travel and Lodging | $3,439.30 |
| Education | $39.99 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,125.97 | 2023-2025 | Da Vinci Surgical System |
| Dendreon Pharmaceuticals LLC | $3,110.44 | 2019-2025 | Provenge |
| Pfizer INC. | $2,101.28 | 2019-2025 | |
| Coloplast Corp | $2,053.13 | 2020-2025 | Titan, Porges Coloplast, Speedicath |
| Boston Scientific Corporation | $1,606.60 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Rezum Generator |
| Teleflex LLC | $1,390.36 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $1,293.66 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $1,251.51 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $1,245.98 | 2019-2025 | Myrbetriq, Xtandi |
| Axonics, INC. | $874.25 | 2020-2024 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $562.73 | 2021-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $531.29 | 2021-2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $530.05 | 2019-2025 | Erleada, Balversa, Akeega |
| Astrazeneca Pharmaceuticals LP | $509.70 | 2020-2025 | Lynparza |
| Abbvie INC. | $457.49 | 2019-2025 |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Rayford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.